Dr. Rama Narsimha Reddy Anreddy
My Social Links

Dr. Rama Narsimha Reddy Anreddy

Professor
Jyothishmathi Institute of Pharmaceutical Sciences, Telangana, India


Highest Degree
Ph.D. in Pharmacology and Toxicology from Kakatiya University, India

Share this Profile

Biography

Dr. Rama Narsimha Reddy Anreddy is currently working as Principal and HOD in Pharmacology Division, Vaageswari College of Pharmacy, Karimnagar, Andhra Pradesh, India. He obtained his Ph.D. in Pharmacology and Toxicology from Kakatiya University, Warangal, India. His area of interest related to Challenging Assignments and Applying new Vistas in the area of Nanoparticles Toxicology, Molecular Toxicology, Pharmacokinetics, Cancer, Diabetes and Drug Development Research. He Guided 15 PG students for their M. Pharmacy dissertation work and currently guiding 6 M. Pharm students. He has published (1) book chapter, (1) patent, and more than (51) articles in national and international journals contributed as presented poster/paper in (5) conferences contributed as author/co-author. He is member of editorial boards in 6 journals.

Area of Interest:

Pharmacology and Toxicology
100%
Diabetes
62%
Toxicology
90%
Pharmaceutics
75%
Drug Metabolism
55%

Research Publications in Numbers

Books
1
Chapters
1
Articles
51
Abstracts
5

Selected Publications

  1. Kumar, A.K., P.K. Raju, C.P. Kumar and A.R.N. Reddy, 2013. Plasma lipid profiles and risk of cardiovascular disease on occupational exposure in Karimnagar. Toxicol. Environ. Chem., 95: 359-366.
    CrossRef  |  
  2. Kiranmai, G. and A.R.N. Reddy, 2013. Antioxidant status in MgO nanoparticle-exposed rats. Toxicol. Ind. Health, 29: 897-903.
    CrossRef  |  PubMed  |  
  3. Reddy, A.R.N., Y.N. Reddy, D.R. Krishna and V. Himabindu, 2012. Pulmonary toxicity assessment of multiwalled carbon nanotubes in rats following intratracheal instillation. Environ. Toxicol., 27: 211-219.
    CrossRef  |  PubMed  |  Direct Link  |  
  4. Reddy, A.R.N., J. Nagaraju, G. Rajyalakshmi and M. Sarangapani, 2012. Cardio protective effect of N-(Benzo[d]oxazol-2-yl)-2-(5-Bromo-2-oxoindolin-3-y lidene) hydrazine carboxamide against doxorubicin induced cardiotoxicity in rats. Toxicol. Environ. Chem., 94: 2012-2018.
    CrossRef  |  Direct Link  |  
  5. Rajyalakshmi, G., A.R.N. Reddy, G. Kiran, Y.N. Reddy and M. Sarangapani, 2012. Synthesis, antimicrobial, antioxidant and anticancer activities of some novel 3-(benzoxazol-2-ylimino) indolin-2-one derivatives. J. Chilean Chem. Soc., 57: 1199-1202.
  6. Rajyalakshmi, G., A.R.N. Reddy and M. Sarangapani, 2012. Synthesis and biological activities of some novel 2-amino-(5 or 7-substituted-2-oxoindolin-3-ylidene) benzoxazole-5-carbohydrazide derivatives. Lett. Drug Design Discovery, 9: 625-632.
    CrossRef  |  Direct Link  |  
  7. Rajyalakshmi, G., A.R.N. Reddy and M. Sarangapani, 2012. In vitro Antioxidant and Antibacterial activities of certain 3-{4-(5-mercapto-1,3,4-oxadiazole-2-yl)phenylimino}-indolin-2-one derivatives. Toxicol. Environ. Chem., 94: 2006-2011.
    CrossRef  |  Direct Link  |  
  8. Rajanarendar, E., S. Raju, M.N. Reddy, S.R. Krishna, L.H. Kiran, A.R.N. Reddy and Y.N. Reddy, 2012. Multi-component synthesis and in vitro and in vivo anticancer activity of novel arylmethylene bis-isoxazolo[4,5-b]pyridine-N-oxides. Eur. J. Med. Chem., 50: 274-279.
    CrossRef  |  PubMed  |  
  9. Rajanarendar, E., M.N. Reddy, K.R. Murthy, P. Surendar, R.N. Reddy and Y.N. Reddy, 2012. Synthesis and in vitro and in vivo anticancer activity of novel phenylmethylene bis-isoxazolo[4,5-b]azepines. Bioorg. Med. Chem. Lett., 22: 149-153.
    CrossRef  |  PubMed  |  Direct Link  |  
  10. Maheshwari, P., B. Baburao and A.R.N. Reddy, 2012. Hepatoprotective activity of methanolic extract of Hiptage bengalensis leaves against CCl4 induced hepatotoxicity in rats. Toxicol. Mech. Meth., 22: 483-487.
    Direct Link  |  
  11. Gantedi, S. and R.N.R. Anreddy, 2012. Toxicological studies of zinc oxide nanomaterials in rats. Toxicol. Environ. Chem., 94: 1768-1779.
    CrossRef  |  Direct Link  |  
  12. Reddy, A.R., Y.N. Reddy, D.R. Krishna and V. Himabindu, 2011. Induction of oxidative stress and cytotoxicity by carbon nanomaterials is dependent on physical properties. Toxic. Indus. Health, 27: 3-10.
    CrossRef  |  PubMed  |  
  13. Reddy, A.R., M.V. Rao, D.R. Krishna, V. Himabindu and Y.N. Reddy, 2011. Evaluation of oxidative stress and antioxidant status in rats following exposure of carbon nanotubes. Regul. Toxic. Pharmacol., 59: 251-257.
    CrossRef  |  
  14. Rajyalakshmi, G., A.R.N. Reddy, Y.N. Reddy and M. Sarangapani, 2011. Synthesis, characterization and anti-cancer activity of some novel 3-(4-[5-mercapto-1, 3, 4-oxadiazole-2-yl] phenylimino)-substituted-indolin-2-one derivatives. Saudi Pharm. J., 19: 153-158.
  15. Rajyalakshmi, G., A.R.N. Reddy and M. Sarangapani, 2011. Synthesis, characterization, anti-cancer and antioxidant activities of some novel N-(benzo[d]oxazol-2-yl) -2-(7 or 5-substituted-2-oxoindolin-3-ylidene) hydrazine-carboxamide derivatives. J. Enzyme Inhib. Med. Chem., 26: 813-818.
  16. Patwari, G.S., A.R.N. Reddy, A.V.N.A. Rao and Y.N. Reddy, 2011. Pharmacological screening of Dikamaliartane-A, A Cycloartane isolated from gum resin, Dikamali. Int. J. Applied Biol. Pharm. Technol., Vol. 2. .
    Direct Link  |  
  17. Venkatesham, A., A.R. Reddy, P. Shankaraiah, Y.N. Reddy, D.R. Krishna and P. Narayana, 2010. Pharmacoepidemiology of diabetes mellitus in southern India. Int. J. Pharma. Sci., 2: 400-403.
    Direct Link  |  
  18. Sunder, A.S., A.R.N. Reddy, Y. Rajeshwar, G. Kiran and D.K. Prasad et al., 2010. Protective effect of methanolic extract of Trianthema portulacastrum in atherosclerotic diet induced renal and hepatic changes in rats. Der Pharmacia Lettre, 2: 540-545.
  19. Sunder, A.S., A.R.N. Reddy, D.K. Prasad, K.P. Chander and S. Vemula, 2010. Free radical scavenging activity of methanolic whole plant extract of Trianthema portulacastrum Linn (Aizoaceae). Int. J. Pharmaceut. Sci., 2: 589-592.
    Direct Link  |  
  20. Sunder, A.S., A.R. Reddy, G. Kiran and S. Thirumurugu, 2010. Anti-hyperlipidemic and antioxidant activity of methanolic extract of Trianthema portulacastrum plant in high fat diet fed rats. J. Herbs Spice Med. Plants, 6: 193-202.
    CrossRef  |  Direct Link  |  
  21. Reddy, A.R., Y.N. Reddy, D.R. Krishna and V. Himabindu, 2010. Translocation and extra pulmonary toxicities of multi wall carbon nanotubes in rats. Toxic. Mechan. Meth., 20: 267-272.
    CrossRef  |  PubMed  |  
  22. Reddy, A.R., Y.N. Reddy, D.R. Krishna and V. Himabindu, 2010. Pulmonary toxicity assessment of multi-wall carbon nanotubes in rats following intratracheal instillation. Environ. Toxic., 10.1002/tox.20632..
    CrossRef  |  
  23. Reddy, A.R., Y.N. Reddy, D.R. Krishna and V. Himabindu, 2010. Multi wall carbon nanoparticles induce oxidative stress and cytotoxicity in human embryonic kidney (HEK293) cells. Toxicology, 272: 11-16.
    CrossRef  |  
  24. Reddy, A.R., Y.N. Reddy, D.R. Krishna and V. Himabindu, 2010. Induction of oxidative stress and cytotoxicity by carbon nanomaterials is dependent on physical properties. Toxic. Indus. Health. 10.1177/0748233710377780.
    CrossRef  |  
  25. Reddy, A.R., Y.N. Reddy, D.R. Krishna and V. Himabindu, 2010. In vitro cytotoxicity of multi wall carbon nanotubes on human cell lines. Environ. Chem., 92: 1697-1703.
    CrossRef  |  Direct Link  |  
  26. Reddy, A.R., P. Mahender, Y.N. Reddy and D.R. Krishna, 2010. Hypoglycemic and hypolipidemic activities of Trianthema portulacastrum plant in normal and alloxan induced diabetic rats. Int. J. Pharmacol., 6: 129-133.
    Direct Link  |  
  27. Radhika, T., P. Mahendar, A. Venkatesham, A.R.N. Reddy, Y.N. Reddy, A. Sadanandam and T. Christopher, 2010. Hypoglycemic activity of red kino tree in normal and streptozotocin induced diabetic rats. Int. J. Pharmacol., 6: 301-305.
    CrossRef  |  Direct Link  |  
  28. Radhika, T., P. Mahendar, A. Venkatesham, A.R. Reddy and Y.N. Reddy et al., 2010. Antioxidant and analgesic activities of Pterocarpus marsupium Roxb. J. Herbs Spice Med. Plants, 16: 63-68.
    CrossRef  |  
  29. Kumar, K.P., A.R. Reddy, Y.N. Reddy and J. Anbu, 2010. Lipid lowering activity of lercanidipine in hyperlipidemic rats. Iranian J. Pharmacol. Therap., 9: 73-75.
    Direct Link  |  
  30. Baburao, B., P.R.S. Rao, A.R.N. Reddy, K. Narasimha, B.R. Narender and Y. Rajeshwar, 2010. In-vitro anti-oxidant activitiy of methanolic extract of Baliospermum montanum. Int. J. Res. Ayurveda Pharm., 1: 611-615.
  31. Baburao, B., A.R. Reddy, B.R. Kumar, Y.N. Reddy and G.K. Mohan, 2010. Analgesic and Anti-inflammatory activities of the methanolic whole plant extract of Leucas cephalotes (Roxb.ex Roth) spreng. Braz. J. Pharm. Sci., 46: 525-529.
    Direct Link  |  
  32. Anreddy, R.N.R., N.R. Yellu, R.K. Devarakonda and H. Vurimindi 2010. In vitro toxicity of multi wall carbon nanoparticles on Hep G 32 liver cell lines. J. Pharmacol. Toxicol., 5: 146-151.
    CrossRef  |  Direct Link  |  
  33. Venkateshwarlu, E., A.R.N. Reddy, A.S Sunder and S. Madhusudhan, 2009. Anti-Hyperglycemic activity of methanolic extract of Salacia fruticosa leaves in alloxan induced diabetic rats. Drug Invent. Today, 1: 95-97.
  34. Rajesham, V.V., G. Rajyalakshmi, A.R.N. Reddy, K. Shekar and J. Anbu, 2009. Effect of nifedipine on the pharmacodynamic parameters of simvastatin in hyperlipidemic rats. J. Pharm. Res., 2: 642-643.
  35. Martha, S., D.R. Krishna, A.R. Reddy and N. Pantam, 2009. Effect of aspirin treatment in streptozotocin-induced type 2 diabetic rats. Meth. Find Exp. Clin. Pharmacol., 31: 331-336.
    CrossRef  |  PubMed  |  
  36. Martha, S., A.R. Reddy, K.R. Devarakonda, N. Pantam, N.R. Yellu and S. Thungathurthi, 2009. Role of liver in progression of insulin resistance in relation to IGF-I and insulin levels in rats with acute hepatotoxicity. Latin Am. J. Pharm., 28: 914-918.
    Direct Link  |  
  37. Laxmi, M.S., A. Venkatesham, A.R.N. Reddy, P. Shankaraiah, D.R. Krishna and Y.N. Reddy, 2009. Glibenclamide therapy in type 2 diabetes. Int. J. Pharm. Sci. Nanotechnol., 2: 385-390.
  38. Katnapally, P.K., A. Janaki, R.N.R. Anreddy and N.R. Yellu, 2009. Pharmacokinetics and pharmacodynamics of atorvastatin alone and in combination with lercanidipine in hyperlipidemic rats. J. Pharm. Res., 2: 66-70.
  39. Gadidasu, K., A.R.N. Reddy, P. Umate, Y.N. Reddy and S. Abbagani, 2009. Antioxidant and anti-diabetic activities from leaf extracts of Streblus asper Lour. Biotechnol. Indian J., 3: 231-235.
  40. Bhukya, B., A.R.N. Reddy and K.M. Gottumukkala, 2009. Analgesic and anti-inflammatory activities of leaf extract of Hiptage benghalensis (L.) Kurz. Biomed. Pharmacol. J., 2: 161-164.
  41. Bhukya, B., A.R. Reddy, C.M. William and K.M. Gottumukkala, 2009. Analgesic and anti-inflammatory activities of leaf extract of Kydia calycina Roxb. Bangladesh J. Pharmacol., 4: 101-104.
    Direct Link  |  
  42. Allenki, V., R.K. Devarakonda, A.R. Reddy, N. Pantam and N.Y. Reddy, 2009. Fasting and Post prandial monitoring of dipeptidyl peptidase-iv (DPP-IV)- A biomarker to assess incretin response in type-2 diabetes. Stamford J. Pharm. Sci., 2: 81-85.
    CrossRef  |  
  43. Rajesham, V.V., A.R. Reddy, J. Anbu and N.Y. Reddy, 2008. Pharmacokinetics of nifedipine in hyperlipidemic rats. J. PharmacoKinetics, 4: 18-31.
  44. Prasad, N., A.R.N. Reddy, A. Venkatesham, S. Pranavi, Y. Venkaiah, D.R. Krishna and M.C. Prabhakara, 2008. Effect of animal bile on the actions of acetylcholine using isolated frogs rectus abdominus muscle. Indian J. Comparat. Anim. Physiol., 26: 23-30.
  45. Prasad, N., A.R.N. Reddy, A. Venkatesham, D.R. Krishna and M.C. Prabhakara, 2008. Antioxidant activity of animal bile using frog heart as a model. Pharmacologyonline, 2: 390-396.
  46. Kumar, K.P., A.R. Reddy, Y.N. Reddy and J. Anbu, 2008. Simultaneous determination of atorvastatin and lercanidipine in rat plasma by HPLC and pharmacokinetic studies. Asian J. Pharmacokinetics Pharmacodynamics, 8: 299-304.
    Direct Link  |  
  47. Kumar, K.P., A.R. Reddy, Y.N. Reddy and J. Anbu, 2008. Effect of hyperlipidemia on the pharmacokinetics of lercanidipine in experimental rats. Pharmacology, 3: 581-585.